web analytics

Infertility

Tuesday, March 22, 2016

08:30-10:00 SOCIAL FREEZING AND FREEZING TO ALL: THE DEBATE CONTINUES
Capsule Female fertility preservation is a potent tool not only for cancer survivors but also for the current delay in family planning and the so called “social freezing”. Should we offer it to all? Freeze-all is also offered to substitute “fresh transfer to a compromised uterus”. What are the evidence?
Chairperson Gab Kovacs, Australia
Zion Ben-Rafael
, Israel
Marie-Madeleine Dolmans, Belgium
08:30-09:15 Debate: Social freezing or simply donor eggs
Social freezing: Kate Stern, Australia
Donor eggs: Gab Kovacs, Australia
Discussion
09:15-10:00 Debate: Are the days of transferring “fresh embryos into a compromised uterus” coming to an end?
Yes: Michael Chapman, Australia
No: Norbert Gleicher, USA
Discussion
10:00-10:20 Coffee break
10:20-11:50 FERTILITY PRESERVATION IN CANCER PATIENTS
Capsule What are the prerequisites for successful preservation program?
Chairpersons Norbert Gleicher, USA
Gab Kovacs, Australia
10:20-10:45 Strategies of cryopreservation: What’s new?
Masashige Kuwayama, Japan
10:45-11:05 Fertility preservation – What to freeze: eggs/embryo/ovarian tissue?
Marie-Madeleine Dolmans, Belgium
11:05-11:30 Impact of apoptosis on follicle loss following cytotoxic treatment
Karla J. Hutt, Australia
11:30-11:50 What clinical results can be expected after re-implantation?
Jacques Donnez, Belgium
11:50-12:10 Break
12:10-13:40 AMH AND POOR OVARIAN RESERVE
Capsule AMH is emerging as a leading test to predict ovarian response but can we do without it? The refinement of the assay promises to make this test more popular.
Chairpersons Norbert Gleicher, USA
Melanie L. Walls, Australia
Ben W.J. Mol, Australia
12:10-12:55 Debate:
Proposition: There is no place for ovarian reserve testing in modern fertility
Ben W.J. Mol, Australia

Position: Ovarian reserve tests are an important tool
Ernest Ng, Hong Kong

Discussion
12:55-13:15 Is there an ideal stimulation for POR?
Gleicher Norbert, USA
13:15-13:40 Endometrioma excision and ovarian reserve
Jacques Donnez, Belgium
16:40-14:30 Lunch break
14:30-16:00 EMBRYO IMPROVEMENT AND SELECTION FOR ET
Capsule Newer techniques promise a better and more efficient selection for transfer and implantation
Chairpersons Rebecca Robker, Australia
Ernest Ng, Hong Kong
14:30-14:55 Embryo selection techniques and methodologies
David K. Gardner, Australia
14:55-15:15 Is there really clinical value in embryo selection?
Norbert Gleicher, USA
15:15-15:40 Mitochondrial transfer for oocyte rejuvenation
Justin St. John, Australia
15:40-16:00 Biomarkers for endometrial receptivity are superior to genetic tests for implantation
Tracey Edgell, Australia
16:00-16:30 Coffee break
16:30-18:00 IMPROVING PREGNANCY RATE BY PGS AND ENDOMETRIAL SCRATCH
Capsule PGS is claimed to be successful in improving pregnancy rate, and some might even argue that it has to be universally applied, but yet differences in reported results and laboratories experience leave doubts on the clinical wisdom and cost effectiveness of expanding the use
Chairperson David K. Gardner, Australia
Gab Kovacs, Australia
16:30-17:15 Debate: PGS is now proven, every embryo should undergo PGS
Yes: Gab Kovacs, Australia
No: Norbert Gleicher, USA
Discussion
Capsule Despite numerous publication on the issue no agreement exist on the value of endometrial scratch to improve implantation
17:15-18:00 Debate:
Proposition: Endometrial scratch can improve implantation
Ernest Ng, Hong Kong
Opposition: No proof that endometrial scratch can improve implantation
Ben W.J. Mol, Australia
Discussion

Wednesday, March 23, 2016

08:30-10:00 IMPROVING SPERM PERFORMANCE
Capsule ICSI is being used with increasing frequency and in some clinics to all patients. ICSI also allows to use round spermatid. Are there any downsides to these practices?
Chairpersons John Aitken, Australia
Geoffry De Iuliis, Australia
08:30-09:30 Debate: ICSI for all cases?
Yes: John Mcbain, Australia
No: John Aitken, Australia
Discussion
09:30-10:00 Why are RCTs rare in infertility and what to do about it?
Norbert Gleicher, USA
10:00-10:20 Coffee break
10:20-11:50 THE ANDROLOGY LAB AND MALE INFERTILITY IN 2016
Capsule Male infertility research and sperm tests are plagued with several limitations that make it doubtful that there will ever be an “ultimate test”
Chairpersons Geoffry De Iuliis, Australia
R. John Aitken
, Australia
10:20-10:50 The ultimate sperm “function test”
R. John Aitken, Australia
10:50-11:20 Measuring sperm DNA damage: Are all tests created equal?
Geoffry De Iuliis, Australia
11:20-11:50 Correlation between morphology, parthenogenesis and karyotype
Budi Wiweko, Indonesia
11:50-12:10 Break
12:10-13:40 OVARIAN STIMULATION IN LOW AND HIGH RESPONDERS
Capsule Effective stimulation of low responders and PCOS re still controversial
Chairpersons David K. Gardner, Australia
Salim Daya, Canada
12:10-12:35 PCOS: A complex reproductive, metabolic and psychology disorder
Helena Teede, Australia
12:35-12:55 Use of metformin to improve outcome with IVF in PCOS
Salim Daya, Canada
12:55-13:40 Debate : Do we need androgen supplementation in women with low ovarian reserve
No: Salim Daya, Canada
Yes: Norbert Gleicher, USA
Discussion
13:40-14:30 Lunch break
14:30-16:00 CONTROLLED OVARIAN STIMULATION
Capsule The ideal stimulation for these patients remains a great challenge for the clinician
Chairpersons John Mcbain, Australia
Ernest Ng, Hong Kong
14:30-14:50 How new infertility treatments negatively affected birth rates around the world over the last 10 years
Gleicher Norbert, USA
14:50-15:15 IVM in PCOS – What results can be expected?
Melanie L. Walls, Australia
15:15-15:40 Obesity-induced metabolic disruption of oocytes: The science behind the clinical relevance
Rebecca Robker, Australia
15:40-16:00 Evidence based luteal support
Salim Daya, Canada
16:00-16:30 Coffee break
16:30-18:00
Hot Controversies
RTD ON CLINICALLY AND LABORATORY RELATED CONTROVERSIES
Chairpersons Zion Ben-Rafael, Israel
Gab Kovacs,
Australia
Discussants David K. Gardner, Australia
Norbert Gleicher,
US
Marie-Madeleine Dolmans,
Belgium
Lyndon Hale
, Australia
Salim Daya, Canada   
Questions to the panel:
  1. Stimulation in Low responders
  2. PCOS after 40 and risk of OHSS
  3. Increased progesterone in the follicular phase and outcome of IVF
  4. Should we use time lapse in all cycles?
  5. Is time lapse a better incubator?
  6. Reversed cleavage: What did we learn so far?
  7. Is there an optimal size of follicle in the day of hCG?
  8. Should we stop doing IVM?
  9. Should we stop “using” assisted hatching?
  10. Is it still worthwhile treating women with own eggs after age 42?
  11. PGS in Decreased Ovarian Reserve, good or bad?